Development of a cAdVax-Based Bivalent Ebola Virus Vaccine That Induces Immune Responses against both the Sudan and Zaire Species of Ebola Virus

Ebola virus (EBOV) causes a severe hemorrhagic fever for which there are currently no vaccines or effective treatments. While lethal human outbreaks have so far been restricted to sub-Saharan Africa, the potential exploitation of EBOV as a biological weapon cannot be ignored. Two species of EBOV, Su...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wang, Danher, Raja, Nicholas U., Trubey, Charles M., Juompan, Laure Y., Luo, Min, Woraratanadharm, Jan, Deitz, Stephen B., Yu, Hong, Swain, Benjamin M., Moore, Kevin M., Pratt, William D., Hart, Mary Kate, Dong, John Y.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2006
Schlagworte:
Vaccines and Antiviral Agents
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1395467/
https://ncbi.nlm.nih.gov/pubmed/16501083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.80.6.2738-2746.2006
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge